We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toPatient-Engagement-in-Pharmacovigilance

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.


Patient Engagement in Pharmacovigilance

    Session Chair(s)
      Deborah E. Collyar

      Deborah E. Collyar

      • President
      • Patient Advocates In Research (PAIR), United States
    This session will present current research and emerging best practices in the field of patient risk communication, including methods for collecting patient input in the design of these communication materials.
    Learning Objective : Discover the likely triggers for a public hearing; Analyse the relationship of public hearings to other parts of the global system Understand how to prepare for a public hearing Reflect on how to apply recognised principles of effective communication
    Speaker(s)
      Emily  Freeman, PhD, MSc

      Patient Engagement and Pharmacovigilance: Risk Interventions and Strategic Communications (RISC)

      Emily Freeman, PhD, MSc

      • Director, Patient Centered Outcomes
      • AbbVie, Inc., United States
      Shelley  Gandhi, MS

      How Will EU Public Hearings Help with Patient and Public Engagement and How Should the Industry Prepare?

      Shelley Gandhi, MS

      • Strategic Advisor
      • NDA Group, United Kingdom
      David  Blaser, PharmD

      Can Patient-Generated Real-World Data Illuminate Real World Evidence of Safety Concerns Sooner Than Traditional Sources?

      David Blaser, PharmD

      • Director, Health Informatics
      • PatientsLikeMe, United States
      Meredith Y. Smith, PhD, MPA

      How Well Are We Doing Conveying Drug Safety Information to Patients? An Analysis of the Quality of REMS Educational Materials

      Meredith Y. Smith, PhD, MPA

      • Global Risk Management Officer, Global Patient Safety
      • Amgen Inc., United States